Study on the mechanism of demethoxycurcumin inhibiting immune escape in nasopharyngeal carcinoma

Read full text Summarise with VIRAT
Authors: Yang-Chun Li, Chao-Cai Zhang, Yong-Shuang Chu, Meng Yang, YAN-XIN REN, Ning Huang
Cited by: 0
References: 43

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Tumor immunotherapy represents a more advanced and effective treatment modality for tumors following targeted therapy. However, the high cost of immune checkpoint inhibitors and the severe immune-related side effects have hindered the widespread application of tumor immunotherapy. In recent years, research on small molecule inhibitors has gained momentum, with notable progress in the exploration of natural small molecule drugs aimed at mitigating tumor immune escape. Investigating potential natural small molecule drugs that interfere with the expression of PD-1/PD-L1 immune checkpoints may represent a novel avenue in tumor immunotherapy. This study uses a combination of bioinformatics analysis and cellular experiments to demonstrate that the genomic characteristics of nasopharyngeal carcinoma are closely associated with the dysregulation of the immune microenvironment. It has also been demonstrated that PD-L1 expression in nasopharyngeal carcinoma cells is reduced by dehydrocurcumin (DMC) through the prevention of the activation of the PI3K/AKT signalling pathway. Furthermore, DMC promotes the polarization of macrophages towards the M1 phenotype while suppressing M2 polarization. This enhances their anti-tumour capabilities. In a mouse model of nasopharyngeal carcinoma, DMC demonstrated a safe and effective capacity to inhibit tumor growth, alleviate liver damage, reduce PD-L1 expression, and enhance CD8+ T cell infiltration and serum IFN-γ levels, thereby comprehensively strengthening the anti-tumor immune response. In conclusion, these findings suggest that DMC can exert anti-nasopharyngeal carcinoma effects by inhibiting the immune escape mechanisms of nasopharyngeal carcinoma and enhancing the tumor immune response.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Curcumin's Biomedical Applications Immune cells in cancer

Publication details

Journal / source
European journal of medical research
Volume
31
Issue
1
Publication date
25 March 2026
Language
EN